MBP1F5

N/A

Report date: 2024/08/23 09:05:22

Base Information

Drug NameMBP1F5
Drug Alias NameMBP1F5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionVirus internalization inhibitors
TargetsUpdating
Therapy Area/IndicationsHenipavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBangladeshIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMapp Biopharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesMapp Biopharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsHenipavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A